Published in BMJ on January 27, 2009
Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2). J Am Med Inform Assoc (2010) 10.51
Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database. BMJ (2010) 5.19
Caveats for the use of operational electronic health record data in comparative effectiveness research. Med Care (2013) 2.89
Rapid, responsive, relevant (R3) research: a call for a rapid learning health research enterprise. Clin Transl Med (2013) 2.10
Rapid identification of myocardial infarction risk associated with diabetes medications using electronic medical records. Diabetes Care (2009) 2.00
Envisioning a learning health care system: the electronic primary care research network, a case study. Ann Fam Med (2012) 1.42
Clinical epidemiology: Archived answers. Nature (2009) 1.39
Applying active learning to high-throughput phenotyping algorithms for electronic health records data. J Am Med Inform Assoc (2013) 1.36
Toward a science of learning systems: a research agenda for the high-functioning Learning Health System. J Am Med Inform Assoc (2014) 1.24
Recommendations for the use of operational electronic health record data in comparative effectiveness research. EGEMS (Wash DC) (2013) 1.09
Preadmission statin use and one-year mortality among patients in intensive care - a cohort study. Crit Care (2010) 1.07
Considerations for using research data to verify clinical data accuracy. AMIA Jt Summits Transl Sci Proc (2014) 0.95
Effectiveness of same versus mixed asthma inhaler devices: a retrospective observational study in primary care. Allergy Asthma Immunol Res (2012) 0.92
Don't take your EHR to heaven, donate it to science: legal and research policies for EHR post mortem. J Am Med Inform Assoc (2013) 0.90
Feasibility of studying brain morphology in major depressive disorder with structural magnetic resonance imaging and clinical data from the electronic medical record: a pilot study. Psychiatry Res (2012) 0.88
Corticosteroid Treatments in Males With Duchenne Muscular Dystrophy: Treatment Duration and Time to Loss of Ambulation. J Child Neurol (2014) 0.85
Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD). BMJ Open (2016) 0.84
Reusing electronic patient data for dental clinical research: a review of current status. J Dent (2013) 0.83
Estimating causal effects in observational studies using Electronic Health Data: Challenges and (some) solutions. EGEMS (Wash DC) (2013) 0.80
Bias and sensitivity analysis when estimating treatment effects from the cox model with omitted covariates. Biometrics (2013) 0.79
Individual and composite study endpoints: separating the wheat from the chaff. Am J Med (2014) 0.78
Use and Customization of Risk Scores for Predicting Cardiovascular Events Using Electronic Health Record Data. J Am Heart Assoc (2017) 0.78
A compilation of research working groups on drug utilisation across Europe. BMC Res Notes (2014) 0.77
Body characteristics, [corrected] dietary protein and body weight regulation. Reconciling conflicting results from intervention and observational studies? PLoS One (2014) 0.77
Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study. BMJ (2016) 0.77
Building a self-measuring healthcare system with computable metrics, data fusion, and substitutable apps. BMJ Outcomes (2015) 0.76
Impact of primary care nursing workforce characteristics on the control of high-blood pressure: a multilevel analysis. BMJ Open (2015) 0.75
Prior event rate ratio adjustment for hidden confounding in observational studies of treatment effectiveness: a pairwise Cox likelihood approach. Stat Med (2016) 0.75
Potential value of electronic prescribing in health economic and outcomes research. Patient Relat Outcome Meas (2010) 0.75
How to control for unmeasured confounding in an observational time-to-event study with exposure incidence information: the treatment choice Cox model. Stat Med (2017) 0.75
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet (1994) 40.72
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med (2000) 29.25
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA (2004) 23.69
Estimating causal effects from large data sets using propensity scores. Ann Intern Med (1997) 19.65
Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med (2000) 19.56
Why we need observational studies to evaluate the effectiveness of health care. BMJ (1996) 17.27
A comparison of observational studies and randomized, controlled trials. N Engl J Med (2000) 14.11
Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables. JAMA (1994) 11.32
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA (2007) 10.50
Evaluating non-randomised intervention studies. Health Technol Assess (2003) 9.69
When are observational studies as credible as randomised trials? Lancet (2004) 6.19
Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA (2001) 5.96
Econometrics in outcomes research: the use of instrumental variables. Annu Rev Public Health (1998) 5.55
A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med (2000) 5.17
The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials. BMJ (1998) 5.05
Randomized trials or observational tribulations? N Engl J Med (2000) 4.49
Rare outcomes, common treatments: analytic strategies using propensity scores. Ann Intern Med (2002) 4.38
Methods in health services research. Interpreting the evidence: choosing between randomised and non-randomised studies. BMJ (1999) 3.96
The incidence of mandated maternity benefits. Am Econ Rev (1994) 3.88
Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies. Lancet (2001) 3.71
Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Epidemiology (2006) 3.54
Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med (1996) 3.35
Beyond randomised versus observational studies. Lancet (2004) 3.11
Instrumental variables: application and limitations. Epidemiology (2006) 3.03
Performance of propensity score calibration--a simulation study. Am J Epidemiol (2007) 2.56
Choosing between randomised and non-randomised studies: a systematic review. Health Technol Assess (1998) 2.49
Any casualties in the clash of randomised and observational evidence? BMJ (2001) 2.37
In defense of pharmacoepidemiology--embracing the yin and yang of drug research. N Engl J Med (2007) 2.15
A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies. Health Technol Assess (2000) 1.96
Developing improved observational methods for evaluating therapeutic effectiveness. Am J Med (1990) 1.93
Approaches to combat with confounding by indication in observational studies of intended drug effects. Pharmacoepidemiol Drug Saf (2003) 1.66
Discussing hidden bias in observational studies. Ann Intern Med (1991) 1.62
A simulation using data from a primary care practice database closely replicated the women's health initiative trial. J Clin Epidemiol (2006) 1.27
Simulation of the Syst-Eur randomized control trial using a primary care electronic medical record was feasible. J Clin Epidemiol (2006) 1.25
Beyond randomized clinical trials: applying clinical experience in the treatment of patients with coronary artery disease. Circulation (1986) 1.11
Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Comparability of entry characteristics and survival in randomized patients and nonrandomized patients meeting randomization criteria. J Am Coll Cardiol (1984) 1.10
Replication of the Scandinavian Simvastatin Survival Study using a primary care medical record database prompted exploration of a new method to address unmeasured confounding. Pharmacoepidemiol Drug Saf (2008) 1.05
Estrogen affects post-menopausal women differently than estrogen plus progestin replacement therapy. Hum Reprod (2007) 1.04
Replicated studies of two randomized trials of angiotensin-converting enzyme inhibitors: further empiric validation of the 'prior event rate ratio' to adjust for unmeasured confounding by indication. Pharmacoepidemiol Drug Saf (2008) 1.03
Hormone therapy and coronary heart disease in young women. Menopause (2008) 1.03
Invited commentary: advancing propensity score methods in epidemiology. Am J Epidemiol (2007) 1.00
Observation and experiment with the efficacy of drugs: a warning example from a cohort of nonsteroidal anti-inflammatory and ulcer-healing drug users. Am J Epidemiol (2001) 0.96
Perspectives on hormone replacement therapy: the Women's Health Initiative and new observational studies sampling the overall population. Fertil Steril (2008) 0.85
Observational studies and randomized trials. N Engl J Med (2000) 0.79
Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA (2011) 5.86
APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med (2013) 5.00
Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol (2009) 4.16
Caveats for the use of operational electronic health record data in comparative effectiveness research. Med Care (2013) 2.89
The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction. Pharmacoepidemiol Drug Saf (2012) 2.70
Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort. Nephrol Dial Transplant (2011) 2.60
Toward reuse of clinical data for research and quality improvement: the end of the beginning? Ann Intern Med (2009) 2.53
Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis (2012) 2.42
Design considerations, architecture, and use of the Mini-Sentinel distributed data system. Pharmacoepidemiol Drug Saf (2012) 2.41
Use of abdominopelvic computed tomography in emergency departments and rates of urgent diagnoses in Crohn's disease. Clin Gastroenterol Hepatol (2011) 2.40
Synergies and distinctions between computational disciplines in biomedical research: perspective from the Clinical andTranslational Science Award programs. Acad Med (2009) 2.25
Who gets the best sleep? Ethnic and socioeconomic factors related to sleep complaints. Sleep Med (2010) 2.10
Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol (2012) 2.10
Measured GFR does not outperform estimated GFR in predicting CKD-related complications. J Am Soc Nephrol (2011) 2.06
Risk of kidney injury following oral phosphosoda bowel preparations. J Am Soc Nephrol (2007) 1.89
CKD in Hispanics: Baseline characteristics from the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic-CRIC Studies. Am J Kidney Dis (2011) 1.88
Risk factors for fluconazole-resistant Candida glabrata bloodstream infections. Arch Intern Med (2009) 1.86
Imipenem resistance among pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes. Infect Control Hosp Epidemiol (2006) 1.76
Previous antimicrobial exposure is associated with drug-resistant urinary tract infections in children. Pediatrics (2010) 1.72
A longitudinal study of left ventricular function and structure from CKD to ESRD: the CRIC study. Clin J Am Soc Nephrol (2013) 1.72
Fibroblast growth factor 23 is not associated with and does not induce arterial calcification. Kidney Int (2013) 1.66
Prognosis for functional deterioration and functional improvement in late life among community-dwelling persons. PM R (2013) 1.65
Racial disparities in hypertension control, but not treatment intensification. Am J Hypertens (2009) 1.59
Retinopathy and cognitive impairment in adults with CKD. Am J Kidney Dis (2012) 1.58
"Sleep disparity" in the population: poor sleep quality is strongly associated with poverty and ethnicity. BMC Public Health (2010) 1.58
Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC). Am Heart J (2010) 1.55
Age and sleep disturbances among American men and women: data from the U.S. Behavioral Risk Factor Surveillance System. Sleep (2012) 1.49
Fibroblast growth factor 23 and Inflammation in CKD. Clin J Am Soc Nephrol (2012) 1.48
All-cause 1-, 5-, and 10-year mortality in elderly people according to activities of daily living stage. J Am Geriatr Soc (2012) 1.48
Fluoroquinolone-resistant Pseudomonas aeruginosa: assessment of risk factors and clinical impact. Am J Med (2006) 1.47
Identification of optimal combinations for empirical dual antimicrobial therapy of Pseudomonas aeruginosa infection: potential role of a Combination Antibiogram. Infect Control Hosp Epidemiol (2006) 1.45
Postdischarge adverse events for 1-day hospital admissions in older adults admitted from the emergency department. Ann Emerg Med (2010) 1.43
Low use of opioid risk reduction strategies in primary care even for high risk patients with chronic pain. J Gen Intern Med (2011) 1.39
The relationship between diabetes, metabolic syndrome, and platelet activity as measured by mean platelet volume: the National Health And Nutrition Examination Survey, 1999-2004. Diabetes Care (2012) 1.36
Barriers to adherence and hypertension control in a racially diverse representative sample of elderly primary care patients. Pharmacoepidemiol Drug Saf (2009) 1.33
Epidemiology and impact of imipenem resistance in Acinetobacter baumannii. Infect Control Hosp Epidemiol (2009) 1.33
Vascular risk factors and cognitive impairment in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study. Clin J Am Soc Nephrol (2010) 1.32
Imipenem resistance in Pseudomonas aeruginosa: emergence, epidemiology, and impact on clinical and economic outcomes. Infect Control Hosp Epidemiol (2010) 1.30
A simulation using data from a primary care practice database closely replicated the women's health initiative trial. J Clin Epidemiol (2006) 1.27
Simulation of the Syst-Eur randomized control trial using a primary care electronic medical record was feasible. J Clin Epidemiol (2006) 1.25
Activity of daily living staging, chronic health conditions, and perceived lack of home accessibility features for elderly people living in the community. J Am Geriatr Soc (2011) 1.25
Staging activity limitation and participation restriction in elderly community-dwelling persons according to difficulties in self-care and domestic life functioning. Am J Phys Med Rehabil (2012) 1.23
Effect of booster seat laws on appropriate restraint use by children 4 to 7 years old involved in crashes. Arch Pediatr Adolesc Med (2007) 1.20
Emergency department lactate is associated with mortality in older adults admitted with and without infections. Acad Emerg Med (2010) 1.17
Retinopathy and chronic kidney disease in the Chronic Renal Insufficiency Cohort (CRIC) study. Arch Ophthalmol (2012) 1.16
Mortality predictive indexes for the community-dwelling elderly US population. J Gen Intern Med (2012) 1.13
Mean platelet volume and prevalence of peripheral artery disease, the National Health and Nutrition Examination Survey, 1999-2004. Atherosclerosis (2010) 1.08
Stockpiling drugs for an avian influenza outbreak: examining the surge in oseltamivir prescriptions during heightened media coverage of the potential for a worldwide pandemic. Infect Control Hosp Epidemiol (2009) 1.08
The impact of concordant and discordant conditions on the quality of care for hyperlipidemia. J Gen Intern Med (2008) 1.07
Obesity, diabetes, and exercise associated with sleep-related complaints in the American population. Z Gesundh Wiss (2011) 1.05
Replication of the Scandinavian Simvastatin Survival Study using a primary care medical record database prompted exploration of a new method to address unmeasured confounding. Pharmacoepidemiol Drug Saf (2008) 1.05
Metabolic syndrome, components, and cardiovascular disease prevalence in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Nephrol (2011) 1.05
Estrogen affects post-menopausal women differently than estrogen plus progestin replacement therapy. Hum Reprod (2007) 1.04
Association between retinopathy and cardiovascular disease in patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC] Study). Am J Cardiol (2012) 1.04
Home accessibility, living circumstances, stage of activity limitation, and nursing home use. Arch Phys Med Rehabil (2012) 1.03
Do elderly people at more severe activity of daily living limitation stages fall more? Am J Phys Med Rehabil (2012) 1.03
Replicated studies of two randomized trials of angiotensin-converting enzyme inhibitors: further empiric validation of the 'prior event rate ratio' to adjust for unmeasured confounding by indication. Pharmacoepidemiol Drug Saf (2008) 1.03
Hormone therapy and coronary heart disease in young women. Menopause (2008) 1.03
Dietary and lifestyle factors associated with blood pressure among U.S. adolescents. J Adolesc Health (2006) 1.03
Clinical effectiveness, access to, and satisfaction with care using a telehomecare substitution intervention: a randomized controlled trial. Int J Telemed Appl (2011) 1.03
Actual financial comparison of four strategies to evaluate patients with potential acute coronary syndromes. Acad Emerg Med (2008) 1.02
Validation of a coding algorithm to identify patients with hepatocellular carcinoma in an administrative database. Pharmacoepidemiol Drug Saf (2012) 1.00
Contact isolation for infection control in hospitalized patients: is patient satisfaction affected? Infect Control Hosp Epidemiol (2008) 1.00
Exploration of ICD-9-CM coding of chronic disease within the Elixhauser Comorbidity Measure in patients with chronic heart failure. Perspect Health Inf Manag (2013) 0.99
Ontology mapping and data discovery for the translational investigator. AMIA Jt Summits Transl Sci Proc (2010) 0.97
Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus. Diabetologia (2014) 0.97
Gastrointestinal tract colonization with fluoroquinolone-resistant Escherichia coli in hospitalized patients: changes over time in risk factors for resistance. Infect Control Hosp Epidemiol (2009) 0.95
Risk factors for peripheral arterial disease among patients with chronic kidney disease. Am J Cardiol (2012) 0.94
Recovery preference exploration: analysis of patient feedback after imagined scenarios. Am J Phys Med Rehabil (2007) 0.93
Heart rate variability is a predictor of mortality in chronic kidney disease: a report from the CRIC Study. Am J Nephrol (2013) 0.92
Previous violent events and mental health outcomes in Guatemala. Am J Public Health (2015) 0.92
Factors influencing decisions to admit patients to veterans affairs specialized rehabilitation units after lower-extremity amputation. Arch Phys Med Rehabil (2009) 0.92
A new "Comparative Effectiveness" assessment strategy using the THIN database: comparison of the cardiac complications of pioglitazone and rosiglitazone. Pharmacoepidemiol Drug Saf (2012) 0.91
High rate of coadministration of di- or tri-valent cation-containing compounds with oral fluoroquinolones: risk factors and potential implications. Infect Control Hosp Epidemiol (2005) 0.89
Insulin therapy and colorectal adenomas in patients with diabetes mellitus. Cancer Epidemiol Biomarkers Prev (2012) 0.88
Incidence and prevalence of abnormal liver associated enzymes in patients with atrial fibrillation in a routine clinical care population. Pharmacoepidemiol Drug Saf (2008) 0.88
Risk factors for gastrointestinal tract colonization with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella species in hospitalized patients. Infect Control Hosp Epidemiol (2012) 0.88
DNA methylation profile associated with rapid decline in kidney function: findings from the CRIC study. Nephrol Dial Transplant (2014) 0.88
Validation of the Kidney Disease Quality of Life Short Form 36 (KDQOL-36) US Spanish and English versions in a cohort of Hispanics with chronic kidney disease. Ethn Dis (2013) 0.88
Detecting pregnancy use of non-hormonal category X medications in electronic medical records. J Am Med Inform Assoc (2011) 0.87
Effect of patient comorbidities on filling of antihypertensive prescriptions. Am J Manag Care (2009) 0.87
Racial differences in primary care opioid risk reduction strategies. Ann Fam Med (2011) 0.87
Impact of antimicrobial stewardship programme changes on unnecessary double anaerobic coverage therapy. J Antimicrob Chemother (2011) 0.86
Perspectives on hormone replacement therapy: the Women's Health Initiative and new observational studies sampling the overall population. Fertil Steril (2008) 0.85
Carotid plaque, carotid intima-media thickness, and coronary calcification equally discriminate prevalent cardiovascular disease in kidney disease. Am J Nephrol (2012) 0.85
Clinical predictors of urgent findings on abdominopelvic CT in emergency department patients with Crohn's disease. Inflamm Bowel Dis (2013) 0.85
Prevalence of and risk factors for acute occlusive arterial injury following pediatric cardiac catheterization: a large single-center cohort study. Catheter Cardiovasc Interv (2013) 0.84
Qualitative analysis of peer coaches' experiences with counseling African Americans about reducing heart disease risk. J Gen Intern Med (2011) 0.84
The impact of continuous pulse oximetry monitoring on intensive care unit admissions from a postsurgical care floor. Anesth Analg (2006) 0.83
Cefepime-resistant Pseudomonas aeruginosa. Emerg Infect Dis (2011) 0.83
A randomized trial of peer coach and office staff support to reduce coronary heart disease risk in African-Americans with uncontrolled hypertension. J Gen Intern Med (2012) 0.83
The effect of telehomecare on heart failure self care. AMIA Annu Symp Proc (2010) 0.83
Comparison of complex versus simple activity of daily living staging: validation of simple stages. Arch Phys Med Rehabil (2013) 0.82
Prior event rate ratio adjustment: numerical studies of a statistical method to address unrecognized confounding in observational studies. Pharmacoepidemiol Drug Saf (2012) 0.82